Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration

Journal of Experimental Medicine

Volumn 172, Issue 6, 1990, Pages 1535-1545

  Clauss, Matthias ^a   Gerlach, M ^a   Gerlach, H ^a   Brett, J ^a   Wang, F ^b   Familletti, P C ^b   Pan, Y C E ^b   Olander, J V ^c   Connolly, D T ^c   Stern, D ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b HOFFMANN LA ROCHE INC   (United States)

^c MONSANTO COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYPEPTIDE; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOSIS; VASCULAR TISSUE;

AMINO ACID SEQUENCE; ANIMAL; BLOOD COAGULATION FACTORS; CELL LINE; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, ION EXCHANGE; COMPARATIVE STUDY; CULTURE MEDIA; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; GUINEA PIGS; HUMAN; IMMUNE SERA; LEUKOCYTES, MONONUCLEAR; LYMPHOKINES; MICE; MOLECULAR SEQUENCE DATA; OSTEOSARCOMA; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, NUCLEIC ACID; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR NECROSIS FACTOR; UMBILICAL VEINS;

EID: 0025688912     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.172.6.1535     Document Type: Article

References (42)

1. Beutler, E, and A. Cerami. 1986. Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature (Land.). 32:584.
2. Old, L. 1986. Tumor necrosis factor. Science (Wash. DC). 230:630.
3. Nawroth, P., D. Handley, G. Matsueda, R. De Waal, H. Ger-lach, D. Blohm, and D. Stern. 1988. Tumor necrosis factor cachectin-induced intravascular fibrin formation in meth A fibrosarcomas. J. Exp Med. 168:637.
4. Nawroth, P., and D. Stem. 1986. Modulation of endothelial cell hemostatic properties by tumor necrosis factor.J. Exp Med. 164:740.
5. Bevilacqua, M., J. Pober, G. Majeau, W. Fiers, R. Cotran, and M. Gimbrone. 1986. Recombinant TNF induces procoagulant activity in endothelium. Proc. Natl Acad. Sci. USA. 83:4533.
6. Nemerson, Y., and R. Bach. 1982. Tissue factor revisited. Prog. Hemostasis Thromh 6:237.
7. Clauss, M., C. Murray, M. Vianna, R. De Waal, G. Thurston, P. Nawroth, H. Gerlach, M. Gerlach, R. Bach, P. Fam-illetti, and D. Stem. 1990. A polypeptide factor produced hy fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/ cachectin J. Biol. Chem. 265:7078.
8. Keck, P., S. Hauser, G. Krivi, K. Sanzo, T. Warren, J. Feder, and D. Connolly. 1989. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science (Wash. DC). 246:1309.
9. Senger, D.R., S.J. Galli, A. Dvorak, C. Rsrruzzi, V. Harvey, and H. Dvorak. 1983. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (Wash. DC). 219:983.
10. Connolly, D., D. Heuvelman, R. Nelson, J. Olander, B. Ep-pley, J. Delfino, N. Siegel, R. Leimbruber, and J. Feder. 1989. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest. 84:1470.
11. Ferrara, N., and W. Henzel. 1989. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161:851.
12. Leung, D., G. Cachianes, W.-J. Kuang, D. Goeddel, and N. Ferrara. 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (Wish. DC). 246:1306.
13. Jaffe, E. 1986. Culture and identification of large vessel endothelial cells. In Biology of Endothelial Cells. E. Jaffe, editor. Martinus Nijhofif, Boston. 1-13.
14. Thornton, S., S. Mueller, and E. Levine. 1983. Human endothelial cells: use of heparin in cloning and long-term serial cultivation. Science (Wash. DC). 222:623.
15. Old, L., R Benacerraf, D. Clarke, E. Carswell, and E. Stockert. 1961. Role of the reticuloendothelial system in the host reaction to neoplasia. Cancer Res. 21:1281.
16. Familletti, P.C., and J.E. Fredericks. 1988. Techniques for mammalian cell immobilization. BioTechnology. 6:41.
17. Nawroth, P., D. Stem, W. Kisiel, and R. Bach. 1985. Cellular requirements for tissue factor generation by perturbed bovine aortic endothelial cells in culture. Thromh Res. 40:677.
18. Canon, S., S. Ross, R. Bach, and A. Guha. 1987. Im-munopurification of human tissue factor using an inhibitory monoclonal antibody. Blood. 70:490.
19. Bach, R., R. Gentry, and Y. Nemerson. 1986. Factor VII binding to tissue factor in reconstituted phospholipid vesicles: Induction of cooperativity by phosphatidylserine. Biochemistry. 25:4007.
20. Fluks, A.J. 1981. Three step isolation of human blood monocytes using discontinuous density gradients of percoll. J. Immun. Methods. 41:225.
21. Quinn, M.T., S. Parthasarthy, and D. Steinberg. 1988. Lyso-phosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atheriogenesis. Proc. Natl. Acad. Sci. USA. 85:2805.
22. Laemmli, U. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T∞. Nature (Lond.). 227:680.
23. Matsudaira, P. 1987. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J. Biol. Chem. 262:10035.
24. Prydz, H., and A. Allison. 1978. Tissue thromboplastin activity of isolated human monocytes. Thromh Haemostasis. 39:582.
25. Brooze, G. 1982. Binding of human factor VII and Vila to monocytes. J. Clin. Invest. 70:526.
26. Lyberg, T., K. Gaidai, S. Evensen, and H. Prydz. 1983. Cellular cooperation in endothelial cell thromboplastin synthesis. Br. J. Haematol. 53:85.
27. Folkman, J. 1985. Tumor angiogenesis. Adv. Cancer Res. 43:175.
28. Dvorak, H. 1986. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. JT. Med. 315:1650.
29. Simionescu, N., and M. Simionescu. 1988. Endothelial Cell Biology. Plenum Publishing Corporation. New York, NY. 458 pp.
30. Del Vecchio, P., A. Siflinger-Bimboim, J. Shepard, R. Bizios, J. Cooper, and A. Malik. 1987. Endothelial monolayer permeability to macromolecules. Fed. Proc. 46:2511.
31. Radish, J., C. Butterfield, and J. Folkman. 1979. Effect of fibrin on cultured vascular endothelium. Tissue & Cell. 11:99.
32. Bloem, L., L. Chen, W. Königsberg, and R. Bach. 1989. Serum stimulation of quiescent human fibroblasts induces the synthesis of tissue factor mRNA followed by the appearance of tissue factor antigen and procoagulant activity.J. Cell Physiol. 139:418.
33. Rifkin, D., and D. Moscatelli. 1989. Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol. 109:1.
34. Folkman, J., and M. Klagsbum. 1986. Angiogenic factors. Science (Wash. DC). 235:442.
35. Tsuboi, R., Y. Sato, and D. Rifkin. 1990. Correlation of cell migration, cell invasion, receptor number, proteinase production, and basic fibroblast growth factor levels in endothelial cells. J. Celt Biol. 110:511.
36. Clark, M., M.-J. Chen, S. Crooke, and J. Bomalaski. 1988. Tumor necrosis factor induces phospholipase A2-activating protein in endothelial cells. Biochem. J. 250:125.
37. Henning, B., S. Goldblum, and C. McClain. 1987. Interleukin 1 and tumor necrosis factor/cachectin increase endothelial permeability in vitro. J. Leukocyte Biol. 42:551A.
38. Brett, J., H. Gerlach, P. Nawroth, S. Steinberg, G. Godman, and D. Stern. 1989. Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J. Exp. Med. 169:1977.
39. Gerlach, H., H. Lieberman, R. Bach, G. Godman, J. Brett, and D. Stern. 1989. Enhanced responsiveness of endothelium in the growing/motile state to tumor necrosis factor/cachectin. J. Exp Med. 170:913.
40. Ding, A., F. Forteu, E. Sanchez, and C. Nathan. 1990. Down-regulation of tumor necrosis factor receptors on macrophages and endothelial cells by microtubule depolymerizing agents. J. Exp Med. 171:715.
41. Brock, T., H. Dvorak, and D. Senger. 1990. Tumor-secreted vascular permeability factor (VPF) increase endothelial cell cytosolic calcium. FASEB (Fed. Am. Soc Exp Biol.) J. 4:2071.
42. Plow, E., D. Freaney, and T. Edgington. 1982. Inhibition of lymphocyte protein synthesis by fibrinogen-derived peptides. J. Immunol. 128:1595.